Immediate Impact
2 by Nobel laureates 3 from Science/Nature 70 standout
Citing Papers
Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Barbara Formisano being referenced
Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?
2006
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-α2b in metastatic melanoma
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Barbara Formisano | 443 | 290 | 192 | 21 | 524 | |
| Boris G. Naraev | 372 | 293 | 219 | 22 | 506 | |
| Tatianna Larman | 262 | 107 | 86 | 23 | 583 | |
| Yasushi Otani | 374 | 66 | 133 | 19 | 593 | |
| Kvols Lk | 419 | 337 | 242 | 22 | 572 | |
| W. Victoria Lai | 523 | 339 | 87 | 23 | 622 | |
| Antonette E. Leon | 251 | 147 | 73 | 24 | 637 | |
| Itsuro Hayashi | 457 | 194 | 29 | 19 | 612 | |
| Monica Verrico | 243 | 142 | 36 | 30 | 463 | |
| Janet Li | 197 | 263 | 101 | 20 | 459 | |
| Marianna Macerelli | 276 | 133 | 198 | 27 | 599 |
All Works
Loading papers...